Assessing Folic Acid in High-Risk Pregnancy for Neural Tube Defects

Aim of this study is to investigate and statistically reveal the prevalence and awareness of folic acid usage in pregnant women who have at least one of the risk factors for neural tube defects, to express the level of knowledge of the determined population on this subject and to present ideas to increase awareness in the society.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neural Tube Defects Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Folic Acid Nervous System Diseases Nervous System Malformations

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Prof. Dr. Cemil Tascioglu City Hospital

Istanbul, Sisli, 34384, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

over 18 years
Under 45 years of age
Having at least one of the risk factors for neural tube defects (family history, MTHFR gene mutation, birth defect with aneuploidy, history of GDM or known DM) for Case Group.
Singleton pregnant women

Exclusion criteria

under 18 years old
Above 45 years old
Multiple pregnancies

Treatment and study plan

Primary outcomes

High awareness level for high-risk pregnant women

Time frame: up to 12 weeks

Pregnant women with at least one risk factor for neural tube defects have statistically higher folic acid use and awareness than control group pregnant women.
Low awareness level for society, regardless of the risk situation

Time frame: up to 12 weeks

Low folic acid knowledge and awareness in the sample groups, regardless of risk status

Sponsors and collaborators

Lead sponsor

Karabuk University

Other

Registry information

Official study title

Evaluating Folic Acid Awareness and Usage in High-Risk Pregnant Women for Neural Tube Defects

Important dates

Study start: 2023
Primary completion: 2023
Study completion: 2023
First posted: Nov 18, 2023
Registry last updated: Nov 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed